Informações:
Falhas:
ID
15393
Descrição
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02150317
Link
https://clinicaltrials.gov/show/NCT02150317
Palavras-chave
Versões (1)
- 29/05/2016 29/05/2016 -
Transferido a
29 de maio de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Advanced Hepatocellular Carcinoma NCT02150317
Eligibility Advanced Hepatocellular Carcinoma NCT02150317
- StudyEvent: Eligibility
Similar models
Eligibility Advanced Hepatocellular Carcinoma NCT02150317
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
age
Item
male or female patients > 18 years and <=70 years of age.
boolean
C0001779 (UMLS CUI [1])
hepatocellular carcinoma
Item
at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
boolean
C2239176 (UMLS CUI [1])
vascular invasion or extrahepatic metastasis
Item
tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
boolean
C0521157 (UMLS CUI [1])
C0474915 (UMLS CUI [2])
C0474915 (UMLS CUI [2])
child a-b level, serum bilirubin
Item
criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
boolean
C4050412 (UMLS CUI [1])
C0428441 (UMLS CUI [2])
C0428441 (UMLS CUI [2])
major organs
Item
no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
boolean
C0026766 (UMLS CUI [1])
white blood cell count
Item
hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
boolean
C0023508 (UMLS CUI [1])
informed consent
Item
patients who can understand this trial and have signed informed consent
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status
Item
patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
boolean
C0525058 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
C0009488 (UMLS CUI [2])
Malignant Neoplasms
Item
patients with a medical history of other malignant tumors
boolean
C0006826 (UMLS CUI [1])
subjects participating in other clinical trials
Item
subjects participating in other clinical trials
boolean
C2348568 (UMLS CUI [1])
Child-Pugh Class C
Item
liver function:child c
boolean
C3831115 (UMLS CUI [1])
no pathological evidence of hepatocellular carcinoma.
Item
no pathological evidence of hepatocellular carcinoma.
boolean
C0205469 (UMLS CUI [1])